In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Joanne Shorthouse

Latest From Joanne Shorthouse

A New Generation Invents Pharma’s Mirrored Future

Young businesses are getting set to disrupt every inch of the healthcare space with digital twin technology. Outlook spoke to two startups on the brink of a data dawn.

Outlook 2022 Artificial Intelligence

MeMed’s Mission: Pressing Its Fingerprint Against AMR

Approved in Europe and just given the US green light, MeMed is making waves in the fight against antimicrobial resistance using advanced "host response" technology. Its CEO talks to In Vivo about strategy, commercialization and earning the right to fantasize.

Business Strategies Companies

Raising The Stakes: Immunocore’s Next Play

Two years into her tenancy as CEO, Bahija Jallal is on the cusp of taking UK biotech Immunocore from a research and development organization to a company with a burgeoning pipeline and a marketed therapy. She talks to In Vivo about validating the platform, an IPO and creating a commercial footprint.

Business Strategies Companies

AI Accelerates In Drug Discovery

Artificial Intelligence has been hyped as a game changer in drug discovery for the last five years. How far has it come, and how far can it go? In Vivo talks to some of the key players that are creating and shaping the future of the industry.

Artificial Intelligence Clinical Trials

At War With A Pandemic: Manufacturing For Our Lives

The rapid development of a vaccine to fight COVID-19 is an effort that will be discussed and admired for centuries to come. The effort to make and deliver the vaccines to those who are most at risk is a battle all of its own. Two manufacturers talk to In Vivo about managing roll out strategies when the whole world is watching.

Manufacturing Market Intelligence

Locked And Bolted: How To Create A Data Fortress

Considering the increasing number of biopharmaceutical companies pursuing more virtual and digital tools, the need for world class digital protection is a pressing challenge. In Vivo talks to two cyber security experts about best practice when securing data assets.

Artificial Intelligence Business Strategies
See All
UsernamePublicRestriction

Register